|
The lead was not returned for analysis.Prior to the analysis, the quality documents accompanying the manufacturing process for this pacemaker and the lead were re-investigated.All production steps were performed accordingly, and in particular the final acceptance test proved the device functions to be as specified.Upon receipt, the pacemaker was properly interrogated, and the memory content was analyzed.Low sensing values, high pacing threshold and a low pacing impedance were documented.During the analysis of the provided iegm episodes, a loss of capture could be confirmed as well.Furthermore, the pacemaker activated the eri battery status on (b)(6) 2020 most likely as a result of the reported devices re-programming to high output settings.The battery, however, was definitely not depleted.In general, a minimum of 6 months from eri to eos needs to be guaranteed for safety reasons, independent of the programmed parameters.In case of high output programming a large proportion of battery capacity has to be reserved by the pacemaker, which may result in triggering of eri.The user will be notified on the programming device that with this parameter combination the device will trigger eri immediately.By acknowledging, the device will activate eri permanently.Thus, the eri status cannot be removed by reprogramming.However, the notification of the eri battery status takes place only upon new device interrogation.The pacemaker was re-initialized on (b)(6) 2021 which reset the eri status.The header of the device was analyzed.The set screws could be easily screwed in and out, there was no foreign material inside the header bores.All dimensions of the header bores were within the range requested by the standard specifications.Also, the spring elements of the pacemaker did not show any deviations.The ability of the device to deliver therapies was verified.The anti-bradycardia pacing pulses proved to be normal and in amplitude and frequency as programmed.There was no indication of a device malfunction.An additional long-term pacing test was initiated.During the test, each pacing pulse was recorded.The evaluation of these pacing pulses documented regular device behavior.There was no intermittent or permanent loss of output.In conclusion, the pacemaker is fully functional.The analysis did not show any deviations from the technical specifications.The analysis revealed that the eri battery status was not declared by a premature battery depletion.Instead, a high output program led the device to switch into the battery status eri.The analysis did not reveal any sign of a material or manufacturing problem.An analysis of the lead itself would be essential to determine the root cause related to loss of capture.
|